BR112013012117A8 - Sistema de distribuição de fármaco iontoforético coempacotado de utilização única coempacotado autocontido, usos de fármaco e de composto de triptano - Google Patents

Sistema de distribuição de fármaco iontoforético coempacotado de utilização única coempacotado autocontido, usos de fármaco e de composto de triptano

Info

Publication number
BR112013012117A8
BR112013012117A8 BR112013012117A BR112013012117A BR112013012117A8 BR 112013012117 A8 BR112013012117 A8 BR 112013012117A8 BR 112013012117 A BR112013012117 A BR 112013012117A BR 112013012117 A BR112013012117 A BR 112013012117A BR 112013012117 A8 BR112013012117 A8 BR 112013012117A8
Authority
BR
Brazil
Prior art keywords
copackaged
delivery system
self
drug delivery
single use
Prior art date
Application number
BR112013012117A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112013012117A2 (pt
Inventor
B Sebree Terri
P Stathopulos Robert
A Vinatoru Mihai
Original Assignee
Nupathe Inc
Teva Pharmaceuticals Int Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nupathe Inc, Teva Pharmaceuticals Int Gmbh filed Critical Nupathe Inc
Publication of BR112013012117A2 publication Critical patent/BR112013012117A2/pt
Publication of BR112013012117A8 publication Critical patent/BR112013012117A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A61N1/303—Constructional details
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
BR112013012117A 2010-11-23 2011-11-09 Sistema de distribuição de fármaco iontoforético coempacotado de utilização única coempacotado autocontido, usos de fármaco e de composto de triptano BR112013012117A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41662310P 2010-11-23 2010-11-23
PCT/US2011/059981 WO2012071175A1 (en) 2010-11-23 2011-11-09 User-activated self-contained co-packaged iontophoretic drug delivery system

Publications (2)

Publication Number Publication Date
BR112013012117A2 BR112013012117A2 (pt) 2016-09-27
BR112013012117A8 true BR112013012117A8 (pt) 2017-10-10

Family

ID=45044724

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013012117A BR112013012117A8 (pt) 2010-11-23 2011-11-09 Sistema de distribuição de fármaco iontoforético coempacotado de utilização única coempacotado autocontido, usos de fármaco e de composto de triptano

Country Status (12)

Country Link
US (1) US9327114B2 (enExample)
EP (1) EP2643048A1 (enExample)
JP (1) JP2013543773A (enExample)
CN (1) CN103228318B (enExample)
AU (1) AU2011332187B2 (enExample)
BR (1) BR112013012117A8 (enExample)
CA (1) CA2817824A1 (enExample)
EA (1) EA026254B1 (enExample)
IL (1) IL226067A0 (enExample)
MX (1) MX336812B (enExample)
NZ (1) NZ610305A (enExample)
WO (1) WO2012071175A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011332187B2 (en) 2010-11-23 2016-03-03 Teva Pharmaceuticals International Gmbh User-activated self-contained co-packaged iontophoretic drug delivery system
US9744353B2 (en) 2012-11-14 2017-08-29 Teva Pharmaceuticals International Gmbh Detection of presence and alignment of a therapeutic agent in an iontophoretic drug delivery device
TW201431570A (zh) 2012-11-22 2014-08-16 Ucb Pharma Gmbh 用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片
ES2694662T3 (es) 2013-07-03 2018-12-26 Lts Lohmann Therapie-Systeme Ag Sistema terapéutico transdérmico con componente electrónico
EP2886153A1 (de) * 2013-12-20 2015-06-24 LTS LOHMANN Therapie-Systeme AG System für die transdermale Abgabe von Wirkstoff
ES2954087T3 (es) 2014-05-20 2023-11-20 Lts Lohmann Therapie Systeme Ag Sistema de administración transdérmica que incluye un mediador de interfase
CN106456567A (zh) 2014-05-20 2017-02-22 Lts勒曼治疗系统股份公司 在经皮递送系统中调节活性剂释放的方法
WO2015177204A1 (en) 2014-05-20 2015-11-26 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system containing rotigotine
JP2016002368A (ja) * 2014-06-18 2016-01-12 日本電信電話株式会社 経皮薬物送達システム
WO2018006069A1 (en) 2016-06-30 2018-01-04 Teva Pharmaceuticals International Gmbh Improved formulations for transdermal pharmaceutical systems
FR3152229A1 (fr) * 2023-08-25 2025-02-28 Feeligreen Dispositif de traitement de la peau

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141359A (en) 1976-08-16 1979-02-27 University Of Utah Epidermal iontophoresis device
US5042975A (en) 1986-07-25 1991-08-27 Rutgers, The State University Of New Jersey Iontotherapeutic device and process and iontotherapeutic unit dose
US4917676A (en) 1986-11-20 1990-04-17 Ciba-Geigy Corporation User-activated transdermal therapeutic system
US4927408A (en) 1988-10-03 1990-05-22 Alza Corporation Electrotransport transdermal system
DE3903794A1 (de) 1989-02-09 1990-08-16 Lohmann Therapie Syst Lts Therapeutisches system zur transdermalen oder transmucosalen verabreichung von wirkstoffen und seine verwendung
US5047007A (en) 1989-12-22 1991-09-10 Medtronic, Inc. Method and apparatus for pulsed iontophoretic drug delivery
US5246418A (en) 1991-12-17 1993-09-21 Becton Dickinson And Company Iontophresis system having features for reducing skin irritation
FR2688106B1 (fr) 1992-02-27 1994-09-09 Lhd Lab Hygiene Dietetique Dispositif de generation d'une tension electrique de forme d'onde predeterminee, appareil ionophoretique d'administration transdermique de medicaments.
US5499967A (en) 1992-02-27 1996-03-19 Societe Anonyme Dite: Laboratoires D'hygiene Societe Anonyme Dite: Et De Dietetique (L.H.D.) Transdermal drug delivery device with waveshape generator
US5310404A (en) * 1992-06-01 1994-05-10 Alza Corporation Iontophoretic delivery device and method of hydrating same
FI944321L (fi) * 1992-11-05 1994-11-16 Becton Dickinson Co Käyttäjäaktivoitu iontoforeettinen laite ja menetelmä sen käyttämiseksi
US5445609A (en) 1993-05-28 1995-08-29 Alza Corporation Electrotransport agent delivery device having a disposable component and a removable liner
US5458569A (en) 1993-06-08 1995-10-17 Becton Dickinson And Company Wearable iontophoresis system
US5533971A (en) 1993-09-03 1996-07-09 Alza Corporation Reduction of skin irritation during electrotransport
JPH08155041A (ja) 1994-12-05 1996-06-18 Advance Co Ltd イオントフォレシス用新規高能率電極システム
US5697896A (en) 1994-12-08 1997-12-16 Alza Corporation Electrotransport delivery device
CA2208132A1 (en) 1994-12-21 1996-06-27 Theratech, Inc. Transdermal delivery system with adhesive overlay and peel seal disc
US5879322A (en) 1995-03-24 1999-03-09 Alza Corporation Self-contained transdermal drug delivery device
IE960312A1 (en) 1995-06-02 1996-12-11 Alza Corp An electrotransport delivery device with voltage boosting¹circuit
ZA964320B (en) 1995-06-05 1997-01-13 Alza Corp Device for transdermal electrotransport delivery of fentanyl and sufentanil
US6881208B1 (en) 1995-06-05 2005-04-19 Joseph B. Phipps Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
US5983130A (en) 1995-06-07 1999-11-09 Alza Corporation Electrotransport agent delivery method and apparatus
US6167301A (en) 1995-08-29 2000-12-26 Flower; Ronald J. Iontophoretic drug delivery device having high-efficiency DC-to-DC energy conversion circuit
DE69633733T2 (de) 1995-08-31 2006-02-02 Hisamitsu Pharmaceutical Co., Inc., Tosu Iontophoretische vorrichtung und entsprechendes verfahren zur steuerung des stromes
US5688232A (en) 1995-09-28 1997-11-18 Becton Dickinson And Company Iontophoretic drug delivery device having an improved controller
US5738647A (en) 1996-09-27 1998-04-14 Becton Dickinson And Company User activated iontophoretic device and method for activating same
US20010009983A1 (en) 1997-09-29 2001-07-26 Drug Delivery Technologies, Inc. Methods for implementing current delivery profiles used in an iontophoretic system
CN1154525C (zh) 1997-12-16 2004-06-23 阿尔扎有限公司 带仿真负载保持稳定给药的调节器
DK1047475T3 (da) 1997-12-17 2007-06-11 Alza Corp Iontoforese med programmeret justering af elektrisk ström
CA2367485A1 (en) 1999-04-12 2000-10-19 Hisamitsu Pharmaceuticals Co., Inc. Device for iontophoresis
US6385488B1 (en) 1999-05-20 2002-05-07 Vyteris, Inc. Circuits for increasing the reliability of an iontophoretic system
US6377848B1 (en) 1999-08-25 2002-04-23 Vyteris, Inc. Devices activating an iontophoretic delivery device
ATE404193T1 (de) 2001-06-05 2008-08-15 Ronald Aung-Din Topische migränetherapie
US6745071B1 (en) 2003-02-21 2004-06-01 Birch Point Medical, Inc. Iontophoretic drug delivery system
EP1893278A2 (en) 2005-06-03 2008-03-05 Trans-Dermal Patents Company, LLC Agent delivery system
US20090005824A1 (en) * 2007-06-29 2009-01-01 Polyplus Battery Company Electrotransport devices, methods and drug electrode assemblies
EP2810688B1 (en) * 2008-12-30 2016-11-16 Teva Pharmaceuticals International GmbH Electronic control of drug delivery system
AU2011332187B2 (en) 2010-11-23 2016-03-03 Teva Pharmaceuticals International Gmbh User-activated self-contained co-packaged iontophoretic drug delivery system

Also Published As

Publication number Publication date
MX336812B (es) 2016-02-02
CN103228318B (zh) 2016-03-23
NZ610305A (en) 2015-10-30
AU2011332187A1 (en) 2013-05-02
BR112013012117A2 (pt) 2016-09-27
CN103228318A (zh) 2013-07-31
US9327114B2 (en) 2016-05-03
EP2643048A1 (en) 2013-10-02
EA201390745A1 (ru) 2014-01-30
MX2013005430A (es) 2013-07-05
CA2817824A1 (en) 2012-05-31
IL226067A0 (en) 2013-06-27
AU2011332187B2 (en) 2016-03-03
JP2013543773A (ja) 2013-12-09
WO2012071175A1 (en) 2012-05-31
US20130296766A1 (en) 2013-11-07
EA026254B1 (ru) 2017-03-31

Similar Documents

Publication Publication Date Title
BR112013012117A8 (pt) Sistema de distribuição de fármaco iontoforético coempacotado de utilização única coempacotado autocontido, usos de fármaco e de composto de triptano
CY1117803T1 (el) Ενωση γουανιδινης
UY30056A1 (es) Administracion transdermica de meptazinol
CL2012002356A1 (es) Compuestos heterociclicos acidos derivados de ariltriazolonas ligadas a bisarilo, inhibidores de receptores de vasopresina v1a y v2; procedimiento de preparacion; composicion farmaceutica; y su uso para tratar y/o prevenir insuficiencia cardiaca aguda y cronica, hiponatremia, entre otras.
BR112017011972A2 (pt) derivados de azabicicloctano como agonistas de fxr para uso no tratamento de doenças hepáticas e gastrintestinais
CY1124331T1 (el) Αυξημενη βιοδιαθεσιμοτητα δραστικης ουσιας σε θεραπεια ναλτρεξονης
BR112015003376A8 (pt) composto ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica e usos de quantidade eficiente de composto ou sal farmaceuticamente aceitável do mesmo ou composição farmacêutica
CR20140321A (es) Sistema de administracion transdermica que contiene buprenofina
UA117451C2 (uk) Терапевтично активні сполуки і способи їх застосування
MX336497B (es) Compuestos de tetrahidro-pirido-piridina y tetrahidro-pirido-pirim idina y su uso como moduladores de los receptores de c5a.
EA201201509A1 (ru) Фармацевтические составы, содержащие пиоглитазон и линаглиптин
GT201300258A (es) Derivados de pirazoloespirocetona para uso como inhibidores de acetil-coa carboxilasa
BR112012032282A2 (pt) administração transdérmica de memantina
HN2012000023A (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
WO2012100043A3 (en) Controlled release oral pharmaceutical dosage forms comprising mgbg
MX344846B (es) Combinacion de granulos cargados activos con activos adicionales.
EA201291211A1 (ru) Фармацевтические композиции, содержащие гидроморфон и налоксон
UA114101C2 (xx) Трансдермальна терапевтична система для введення фентанілу або його аналога
CR20150266A (es) Formulaciones de liberación modificada para oprozomib
CR20140358A (es) Sistema para la administración de fármacos
UY33348A (es) Compuestos de furopiridina y usos de los mismos
EP4302825A3 (en) Pharmaceutical compositions for treatment of inappetence
AR109012A1 (es) Sistema de administración transdérmica que contiene galantamina o sales de esta
CO7121334A2 (es) Formulaciones vesiculares
CR20110022A (es) Nuevas posibilidades de lucha contra la giardiasis

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: TEVA PHARMACEUTICALS INTERNATIONAL GMBH (CH)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2487 DE 04-09-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.